Company Name |
Toyobo Biologics Inc. (TBI) |
| President |
Shin Shimizu, Ph.D. |
| Date of Establishment |
November 15, 2001 |
| Capital |
100 million yen |
| Employees |
27 (as of April, 2007) |
| Head Office Address |
2-2-8, Dojimahama, Kita-ku, Osaka-Shi, Osaka |
| Katata Plant |
2-1-1, Katata, Otsu-Shi, Shiga |
|
|
|
President |
Shin Shimizu, Ph.D. |
| Director |
Kazuo Kurita |
| Director |
Setsuo Kobayashi |
| Director |
Kazuo Okumura |
| Auditor |
Hiroshige Nose |
|
|
1979 : |
Toyobo entered the pharmaceutical field. |
| 1989 : |
Application for the approval of tPA (Tissue Plasminogen Activator) submitted. |
| 1990 : |
Otsu Pharmaceutical Plant completed. |
| 1990 : |
Application for the approval of EPO (Erythropoietin) submitted. |
| 1991 : |
tPA approved. |
| 1996 : |
Toyobo started the contract manufacturing pharmaceutical business. |
| 2001 : |
PAC Biologics Inc. was established. |
| 2003 : |
A cell bioreactor plant to house a 4,000L bioreactor was completed. |
| 2004 : |
The validation of the cell culture and purification facilities was completed and full-scale operations were begun. |
|
 |
|
Toyobo Biologics Inc. (TBI)
2-1-1, Katata, Otsu-Shi, Shiga, 520-0292
Tel:81-77-571-0128 Fax:81-77-571-0114
E-Mail:info@toyobobiologics.com |
[contact]
Pharmaceuticals Operating Department Toyobo Co., Ltd.
2-8, DojimaHama2-chome, Kita-ku, Osaka
530-8230, Japan
Tel:81-6-6348-3690 Fax:81-6-6348-3696 |
|
|
|
|
 |
|
| 2007 Copyright Toyobo Biologics Inc. All Rights Reserved. |
|
|
|
PAGE
TOP